Celldex Therapeutics Inc (CLDX)

NASDAQ · Biotechnology

30.10
+0.21 (+0.70%)
Updated Oct 31, 8:36 PM ET
AI Rating
Hold
Overall Score
44
Trend
30
Momentum
50
Risk
58

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 17, 2025 260 sessions Oct 29, 2026

AI Analysis

Celldex Therapeutics Inc is trading at $30.10, up 0.70% on the session. The 50 day average sits at $34.25 and the 200 day at $32.63, which puts the stock in a uptrend. RSI is at 44.2, which reads as weak, and MACD is bullish crossover. Volume is below average.

The nearest support is around $28.20 with resistance near $30.82, so that band frames the current range. Average daily movement is roughly $1.41, or about 4.7% of the share price, which is what any stop placement has to allow for. The overall health score of 44 out of 100 combines a trend score of 30, momentum of 50 and a risk score of 58.

Technical indicators

RSI (14)
44.2
weak
MACD
-1.191
bullish crossover
SMA 20
29.68
SMA 50
34.25
SMA 200
32.63
uptrend
ATR (14)
1.41
avg daily range
Support
28.20
Resistance
30.82
Volume vs 20d
0.67x
below average
Volatility
51.1%
annualised
1 month
-7.78%
3 months
-21.47%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.